ADA Professional Publications
LightNews LightNews
banner
adapubs.bsky.social
ADA Professional Publications
@adapubs.bsky.social
42 followers 27 following 170 posts
ADA’s Professional Publications—Diabetes, Diabetes Care, Clinical Diabetes, Diabetes Spectrum, Diabetes, Obesity & Cardiometabolic Care, and books—are leading sources on diabetes research, care, prevention & treatment. @amdiabetesassn.bsky.social
Posts Replies Media Videos
Pinned
adapubs.bsky.social
ADA Professional Publications @adapubs.bsky.social · 3d
For 40+ years, Clinical Diabetes® and Diabetes Spectrum® advanced the ADA mission, delivering practical, evidence-based guidance shaping diabetes care. Their final issues honor the voices and ideas that supported millions.

📈 Stay tuned for more from ADA Publications and don’t miss the final issues!
Covers of "Clinical Diabetes" and "Diabetes Spectrum" journals. The left cover features a blue background with images of butterflies and titles of feature articles. The right cover shows three individuals, one adult and two children, engaging over a meal, with text about managing Type 2 diabetes.
adapubs.bsky.social
Women with previous gestational diabetes mellitus complete lifestyle programs that meet their priorities. We must educate about the availability of programs and improve access to a variety of lifestyle interventions.

Read here ➡️ doi.org/10.2337/doc25-0019
January 26, 2026 at 4:45 PM
adapubs.bsky.social
Maternal Obesity Leads to Muscle Dysfunction via H19-Mediated Programming of Insulin-Like Growth Factor 2 Signaling

Read here ➡️ doi.org/10.2337/db25-0271
Illustration showing the impact of maternal obesity on neonatal epigenetic modification and offspring muscle development. The diagram traces how maternal obesity affects the neonate, leading to epigenetic changes involving DNA methylation and histone modifications at the Igf2 promoters, which ultimately result in impaired muscle development in offspring.
January 25, 2026 at 7:12 PM
adapubs.bsky.social
Phosphatidylserine Supplementation Improves Metabolic Liver Disease and Glycemic Control in the Presence of Suppressed Oxidative Glucose Metabolism

Read here ➡️ doi.org/10.2337/db25-0588
Illustration depicting the benefits of phosphatidylserine supplementation on metabolic dysfunction-associated steatohepatitis (MASLD) and related conditions. It shows how supplementation improves MASLD fibrosis, glycemic control, and glycogen storage in the liver, enhancing overall lipid utilization. Visual includes diagrams of liver tissue and molecular pathways.
January 24, 2026 at 8:51 PM
adapubs.bsky.social
Addressing type 2 diabetes mechanisms could improve type 1 diabetes prediction and prevention.

Read here ➡️ doi.org/10.2337/db25-0711
Graphic titled "Type2 Diabetes TrialNet" from Diabetes TrialNet illustrating how T2D genetic risk influences metabolic diversity and progresses preclinical Type 1 Diabetes. The graph includes metrics like AUC peptide, BMI z-score, insulin secretion, and features charts showing the relationship of T1D-GRS2 and time to Stage 3 across different figures.
January 23, 2026 at 9:35 PM
adapubs.bsky.social
Identifying Insulin Autoantibodies With Differential Risk in Type 1 Diabetes With a Novel Bridging ELISA

Read more ➡️ doi.org/10.2337/db25-0696
A list of highlights from the linked article
January 23, 2026 at 6:00 PM
adapubs.bsky.social
For 40+ years, Clinical Diabetes® and Diabetes Spectrum® advanced the ADA mission, delivering practical, evidence-based guidance shaping diabetes care. Their final issues honor the voices and ideas that supported millions.

📈 Stay tuned for more from ADA Publications and don’t miss the final issues!
Covers of "Clinical Diabetes" and "Diabetes Spectrum" journals. The left cover features a blue background with images of butterflies and titles of feature articles. The right cover shows three individuals, one adult and two children, engaging over a meal, with text about managing Type 2 diabetes.
January 23, 2026 at 3:46 PM
adapubs.bsky.social
Through a QI initiative, the University of Michigan pediatric diabetes program increased CGM adoption and use and virtually eliminated disparities between non-Hispanic White and non-White patients.

Read here ➡️ doi.org/10.2337/doc25-0042
Line graph showing the percentage of patients who have CGM, comparing Non-Hispanic White Patients and Non-White Patients from February 2022 to June 2024 across several PDSA cycles. The graph illustrates an increase in percentages over time for both groups, with specific data points marked at each PDSA cycle.
January 22, 2026 at 9:50 PM
adapubs.bsky.social
Prolonged Semaglutide Treatment Reveals Stage-Dependent Changes to Feeding Behavior and Metabolic Adaptations in Male Mice

Read here ➡️ doi.org/10.2337/db25-0678
Flowchart titled 'Mechanisms of Rapid Weight Loss and Recovery' from University School of Medicine Boston. It features a timeline divided into four phases: Week 1, Week 2, Week 3, and Week 4, indicating changes in body weight, meal size and number, food intake, energy expenditure, and substrate oxidation through various stages of weight loss and recovery.
January 22, 2026 at 8:00 PM
adapubs.bsky.social
⭐ 📖 Paper of the Month: Feb.
B Lymphocytes Impede Tregs to Erode Islet Tolerance in Type 1 Diabetes
Wilson et al.
➡️ https://doi.org/10.2337/db25-0241

Articles are chosen 🗓️ monthly & 🆓 to read online #paperofthemonth #diabetes
Hidden in the shadows, B lymphocytes contribute to T1D by eliminating the regulatory T cells that would otherwise protect the islet beta cells. Image courtesy of C.S. Wilson. The original image was created by hand with watercolor, scanned and edited in GIMP, and smoothed and pixel enhanced by GPT5.
January 21, 2026 at 8:15 PM
adapubs.bsky.social
First real-world trial of insulin-only #FCL #AID (no meal bolus) in adults & teens with #T1D shows improved glycemia, especially in high HbA1c users, which could improve burden and broaden access.

Read here ➡️ https://doi.org/10.2337/dc25-1526

Infographic depicting a medical study on Adaptive Insulin Delivery (AID) in Type 1 Diabetes. The layout includes background information, study design, primary outcome, and key takeaways presented with charts, graphs, and text summaries. The study compares HbA1c levels, time in target glucose range, and improvement metrics between manual and automated insulin dosing.
January 21, 2026 at 6:35 PM
adapubs.bsky.social
SPINK1 variants in trans cause hereditary pancreatitis with fibrocalcific diabetes: a reminder to consider type 3c diabetes in young adults.

Read here ➡️ doi.org/10.2337/dc25-2135
Early-Onset Fibrocalculous Pancreatic Diabetes Associated With SPINK1 Variants in Trans: A Rare Genetic Case
Paulina Kostrzewska, Paweł Kuca, Roman Łaz, Agnieszka Maksymiuk-Kłos, Przemysław Witek; Early-Onset Fibrocalculous Pancreatic Diabetes Associated With SPIN
doi.org
January 20, 2026 at 10:45 PM
adapubs.bsky.social
👀 The Feb 2026 issue of Diabetes Care is here, with the latest research on #diabetes management & care.

🔗 http://diabetesjournals.org/care/issue/49/2

Featuring:
✨ Study of Drinks w Artificial Sweeteners (SODAS)
✨ Oral Semaglutide & Kidney Outcomes
✨ & more!
Chronicles of Four Unsung Heroes of Diabetes Research, illustration, 2025, Eleonora Nigro. An illustration of three figures sliding along a trail of stars produced by a time machine piloted by a rabbit.
January 20, 2026 at 9:47 PM
adapubs.bsky.social
🚨The February 2026 issue of Diabetes has arrived!

🔗 diabetesjournals.org/diabetes/iss...

Explore the latest research on #diabetes, including:
✨T2D Genetic Risk & T1D Heterogeneity
✨Semaglutide Treatment & Feeding Behaviors
✨& more!
Hidden in the shadows, B lymphocytes contribute to T1D by eliminating the regulatory T cells that would otherwise protect the islet beta cells. Image courtesy of C.S. Wilson. The original image was created by hand with watercolor, scanned and edited in GIMP, and smoothed and pixel enhanced by GPT5.
January 20, 2026 at 8:33 PM
adapubs.bsky.social
Recent ADA guidelines recommend shared decision-making for obesity management in people with type 2 diabetes. This approach has merits but can be challenging to put into practice. Learn more here.

Read here ➡️ doi.org/10.2337/dci25-0094
Infographic titled "The New Obesity Treatment Landscape: Challenges and Opportunities To Promote Shared Decision-Making in People With Obesity and Type 2 Diabetes." It features a central circle divided into three sections labeled "System-level influences," "Provider-level influences," and "Patient-level influences," illustrated with simple icons of a healthcare facility, two individuals with documents, and a person. Surrounding text outlines various strategic points and challenges related to shared decision-making in obesity treatment.
January 19, 2026 at 4:05 PM
adapubs.bsky.social
Among youth delivering ≤3 boluses/day, Control-IQ users spent 8% more TIR than Omnipod 5 users likely due to 16% more time in automated insulin delivery and 6.6 AID-initiated boluses/day.

Read here ➡️ doi.org/10.2337/dc25-2082
Graphical presentation comparing the effectiveness of the Control-IQ system versus a manual system for insulin delivery in youth, showing differences in Time in Range (TIR) and other metrics, using data tables and probability modeling.
January 18, 2026 at 8:14 PM
adapubs.bsky.social
Metabolic dysfunction–associated steatotic liver disease (MASLD) has emerged as a global epidemic, yet its underlying molecular mechanisms remain elusive, and therapeutic options are limited.

Read here ➡️ doi.org/10.2337/db25-0344
Illustration depicting the impact of a high-fat diet versus fasting on adiponectin secretion and fatty acid oxidation. It shows molecular structures related to adipose-specific TGR5 receptor knockout and its consequences.
January 18, 2026 at 7:15 PM
adapubs.bsky.social
Children exposed to GDM diagnosed early in gestation, regardless of treatment type, meeting glycemic targets, or maternal pre-pregnancy BMI, are more likely to develop obesity up to 11 years later.

Read here ➡️ doi.org/10.2337/dc25-1093
Infographic titled 'SWIFT: Prospective Cohort of Women with Gestational Diabetes Mellitus (GDM) and Offspring', showing a timeline from 2008-2022 for cohort recruitment, research phases, and data collection. It includes data on long-term follow-up until 2023, statistics on childhood obesity at 5-11 years, and timing of GDM diagnosis. Icons represent pregnancy, electronic health records, and follow-up stages.
January 17, 2026 at 6:11 PM
adapubs.bsky.social
Type 1 diabetes in older individuals presents with unique care needs that change over time. Individualized goals, optimized use of technologies, and age-friendly models are critical to optimize care.

Read here ➡️ doi.org/10.2337/dci25-0078
Infographic titled 'Improving Care for Type 1 Diabetes in Older Adulthood'. Includes sections on epidemiology, challenges, care approaches, and strategies for improvement, highlighting areas such as risk factors, management techniques, and care needs for older adults with Type 1 Diabetes. Uses diagrammatic representations and bullet points for clear communication.
January 16, 2026 at 6:27 PM
adapubs.bsky.social
The effect of #glimepiride, #insulin #glargine, #liraglutide or #sitagliptin on the islet #α-cell does not impact glycemia progression in type 2 #diabetes, whereas their effect on the #β-cell does.

Read here ➡️ doi.org/10.2337/dc25-2186
Infographic from the GRADE study comparing the effectiveness of glucose-lowering medications on glycemic reduction and metabolic parameters over time. Includes charts showing patient randomization, fasting glucose levels, glucose control over time, and HbA1c outcomes.
January 16, 2026 at 12:45 AM
adapubs.bsky.social
🚨 NEW special #podcast

In pt 2 of this special series of Diabetes Core Update, Neil Skolnik explores automated insulin delivery for patients with T2D, and the practical aspects of prescribing what can be intimidating tech.

👂 Listen now at: diabetesjournals.org/journals/pages/podcasts_aid_t2d
January 15, 2026 at 8:51 PM
adapubs.bsky.social
🚨 The final issue of Diabetes Spectrum is live!

This bonus fifth issue of the journal’s 38th and final volume offers 120 pages of insights on anxiety & T1D, glucose extremes & neurological impacts, and more!

📖Read now ➡️ diabetesjournals.org/spectrum/issue/38/5

Stay ahead in #diabetes care!
A happy family sits around a breakfast table, with a large plate of sliced cantaloupe. Credit: monkeybusinessimages/iStock
January 15, 2026 at 8:15 PM
adapubs.bsky.social
In children with hepatic steatosis, following liver chemistry identifies which children will develop type 2 diabetes. #MASLD #diabetes #pediatrics #NIH

Read here ➡️ doi.org/10.2337/dc25-1532
Infographic illustrating the prediction of Type 2 diabetes in children with metabolic dysfunction-associated steatotic liver disease over a mean follow-up of 4 years. The image indicates 1,035 children were studied, and increases in liver enzymes (GGT increased risk by 50%, AST by 31%, and ALT by 13%) indicate higher diabetes risk. The graphic concludes that longitudinal increases in liver enzymes predict diabetes risk in children with MASLD.
January 15, 2026 at 7:28 PM
adapubs.bsky.social
Racial disparities in diabetes technology utilization persist.

Read here ➡️ doi.org/10.2337/ds25-0023
Infographic illustrating racial disparities in insulin pump use and A1C levels among youth with Type 1 Diabetes in the United States. It includes various pie charts and bar graphs comparing insulin pump usage and A1C levels among children of different racial groups, highlighting higher A1C in Black youth without insulin pump use compared to other races. The document provides statistics, policy insights, and calls for further investigation into these disparities.
January 14, 2026 at 2:30 PM
adapubs.bsky.social
Ligand-receptor interactions of the IGHG and FCGR gene products probably influence progression, shedding new insights into some of the immunological mechanisms involved in progression to Type 1 Diabetes

Read here ➡️ doi.org/10.2337/db25-0610

A scientific diagram illustrating the progression mechanism of Type-1 Diabetes with graphs and molecular interactions. The left graph shows positive interaction trends with a green shaded area, while the right graph displays negative interaction trends in red. Between the graphs, detailed molecular interactions involving IgG and FcγR are depicted, including binding diagrams and a statistical table highlighting data from a cohort study on FGF and TNF07 genes. The image is labeled with terms like "Depth-1 + TN07 genes," "FcγR Interaction," "Methodology," and "Stage 3-stage 1 interactions" associated with Diabetes Prevention Trial.
January 13, 2026 at 10:48 PM
adapubs.bsky.social
📘 The first article from Diabetes, Obesity, and Cardiometabolic CARE is now published.

This Standards of Care in Overweight and Obesity article provides evidence-based guidance on using obesity medications as part of comprehensive care.

🔗 Read the article: doi.org/10.2337/doci25-0008
"Image titled 'Discussing Obesity Medications' lists recommendations for selecting obesity medications. Emphasizes a person-centered approach, combining treatments with lifestyle changes, and minimizing weight-promoting meds when suitable."
January 13, 2026 at 7:58 PM